Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06521840 · ClinicalTrials.gov registry record
Non-invasive Point-Of-Care Hemoglobin Testing In An Obstetric Population
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 124
- Enrollment target
NCT06521840 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 124 participants.
The verdict
NCT06521840 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 124 participants
- Enrollment target
Study Summary
Anemia is common during pregnancy due to increased metabolic rate and normal physiologic changes associated with pregnancy. Anemia during pregnancy has been associated with increased of adverse outcomes during delivery and the postpartum period. Currently, it is recommended to screen for anemia at three pre-specified points during routine prenatal care, typically 3 months apart. This screening method may miss patients who develop anemia between these intervals and lead to a delay in diagnosis and treatment. MasimoTM has developed a non-invasive device that can detect anemia without a blood draw. This device has not been extensively studied in pregnant patients. The aim of this study is to determine the agreement in hemoglobin readings between the non-invasive device and the standard of care blood draws in pregnant patients.
Interventions
- DEVICE Masimo RAD 67
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2024-12-01 |
| Est. Completion | 2025-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06521840
The ClinicalTrials.gov registry entry for NCT06521840 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Masimo RAD 67 is the first listed.
NCT06521840 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06521840 about?
NCT06521840 is a clinical study titled "Non-invasive Point-Of-Care Hemoglobin Testing In An Obstetric Population". Anemia is common during pregnancy due to increased metabolic rate and normal physiologic changes associated with pregnancy. Anemia during pregnancy has been associated with increased of adverse outcomes during delivery and the postpartum period. Currently, it is recommended to screen for anemia at t...
What is the current status of trial NCT06521840?
This trial is currently completed. The enrollment target is 124 participants. The study started on 2024-12-01. Estimated completion is 2025-09-01.
What interventions are being tested in trial NCT06521840?
The interventions under investigation include: Masimo RAD 67 (DEVICE).
Who is sponsoring clinical trial NCT06521840?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.